2-[2-(3,4-difluoro-2-methylphenoxy)-4-methyl-5-(trifluoromethyl)-3-pyridinyl]-4-phenylmethoxy-1,6-naphthyridine
C29H20F5N3O2 — CID 170522863
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-(3,4-difluoro-2-methylphenoxy)-4-methyl-5-(trifluoromethyl)-3-pyridinyl]-4-phenylmethoxy-1,6-naphthyridine
2-[2-(3,4-difluoro-2-methylphenoxy)-4-methyl-5-(trifluoromethyl)-3-pyridinyl]-4-phenylmethoxy-1,6-naphthyridine (PubChem CID 170522863) has the molecular formula C29H20F5N3O2 and a molecular weight of 537.49 g/mol. Its IUPAC name is 2-[2-(3,4-difluoro-2-methylphenoxy)-4-methyl-5-(trifluoromethyl)-3-pyridinyl]-4-phenylmethoxy-1,6-naphthyridine.
Molecular Properties
| Compound Name | 2-[2-(3,4-difluoro-2-methylphenoxy)-4-methyl-5-(trifluoromethyl)-3-pyridinyl]-4-phenylmethoxy-1,6-naphthyridine |
|---|---|
| PubChem CID | 170522863 |
| Molecular Formula | C29H20F5N3O2 |
| Molecular Weight | 537.49 g/mol |
| Exact Mass | 537.15 |
| IUPAC Name | 2-[2-(3,4-difluoro-2-methylphenoxy)-4-methyl-5-(trifluoromethyl)-3-pyridinyl]-4-phenylmethoxy-1,6-naphthyridine |
| SMILES | Cc1c(Oc2ncc(C(F)(F)F)c(C)c2-c2cc(OCc3ccccc3)c3cnccc3n2)ccc(F)c1F |
| InChI | InChI=1S/C29H20F5N3O2/c1-16-20(29(32,33)34)14-36-28(39-24-9-8-21(30)27(31)17(24)2)26(16)23-12-25(19-13-35-11-10-22(19)37-23)38-15-18-6-4-3-5-7-18/h3-14H,15H2,1-2H3 |
| InChIKey | CHEJUIVUYFFQKE-UHFFFAOYSA-N |
| XLogP | 7.98 |
| TPSA | 57.13 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 537.49 |
| LogP ≤ 5 | 7.98 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170522863 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.